Efficacy and Safety of Ejiao (Asini Corii Colla) in Women With Blood Deficient Symptoms: A Randomized, Double-Blind, and Placebo-Controlled Clinical Trial

Equus asinus L [Equidae; Asini Corii Colla] (donkey-hide gelatin, Ejiao), a well-known traditional Chinese medicine, has been widely used to nourish the blood, especially for women. The aim of this study was to assess the efficacy and safety of Ejiao in blood-deficient patients. A total of 210 parti...

Full description

Bibliographic Details
Main Authors: Li Zhang, Zhongju Xu, Tao Jiang, Jialu Zhang, Pinxian Huang, Jiaqi Tan, Gan Chen, Man Yuan, Zhuo Li, Haibin Liu, Dengfeng Gao, Lianbo Xiao, Hui Feng, Jiatuo Xu, Hongxi Xu
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-10-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2021.718154/full
_version_ 1831770849313554432
author Li Zhang
Li Zhang
Zhongju Xu
Tao Jiang
Jialu Zhang
Pinxian Huang
Jiaqi Tan
Gan Chen
Man Yuan
Zhuo Li
Haibin Liu
Dengfeng Gao
Lianbo Xiao
Hui Feng
Jiatuo Xu
Hongxi Xu
Hongxi Xu
author_facet Li Zhang
Li Zhang
Zhongju Xu
Tao Jiang
Jialu Zhang
Pinxian Huang
Jiaqi Tan
Gan Chen
Man Yuan
Zhuo Li
Haibin Liu
Dengfeng Gao
Lianbo Xiao
Hui Feng
Jiatuo Xu
Hongxi Xu
Hongxi Xu
author_sort Li Zhang
collection DOAJ
description Equus asinus L [Equidae; Asini Corii Colla] (donkey-hide gelatin, Ejiao), a well-known traditional Chinese medicine, has been widely used to nourish the blood, especially for women. The aim of this study was to assess the efficacy and safety of Ejiao in blood-deficient patients. A total of 210 participants were recruited and randomly allocated into the placebo control group and Ejiao-treated group (6 g/day). The primary outcomes on the efficacy of Ejiao included traditional Chinese medicine symptom scores, blood indicators, and SF-36. The secondary outcomes were changes in fireness and safety evaluation. Results showed that Ejiao treatment for 8 weeks had significantly improved dizziness symptoms. Among the tested 24 blood biochemical parameters, the hematocrit and red blood cell numbers decreased in the placebo control group, but decreased significantly less in the Ejiao treatment group. The white blood cell and neutrophil counts increased in the Ejiao group but were within the normal range. In addition, the quality of life improved as the scores in SF-36 domains were significantly higher in the Ejiao group. At the same time, there was no significant change in the fire–heat symptoms score or other safety parameters. Considering all these, our study showed that Ejiao has a promising effect in women suffering from blood deficiency without obvious adverse effects.
first_indexed 2024-12-22T07:47:49Z
format Article
id doaj.art-eae64a0a64e34cdda8693f875ba7f989
institution Directory Open Access Journal
issn 1663-9812
language English
last_indexed 2024-12-22T07:47:49Z
publishDate 2021-10-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pharmacology
spelling doaj.art-eae64a0a64e34cdda8693f875ba7f9892022-12-21T18:33:35ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122021-10-011210.3389/fphar.2021.718154718154Efficacy and Safety of Ejiao (Asini Corii Colla) in Women With Blood Deficient Symptoms: A Randomized, Double-Blind, and Placebo-Controlled Clinical TrialLi Zhang0Li Zhang1Zhongju Xu2Tao Jiang3Jialu Zhang4Pinxian Huang5Jiaqi Tan6Gan Chen7Man Yuan8Zhuo Li9Haibin Liu10Dengfeng Gao11Lianbo Xiao12Hui Feng13Jiatuo Xu14Hongxi Xu15Hongxi Xu16Institute of Arthritis Research, Guanghua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, ChinaSchool of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai, ChinaInstitute of Arthritis Research, Guanghua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, ChinaSchool of Basic Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, ChinaSchool of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai, ChinaSchool of Basic Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, ChinaSchool of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai, ChinaSchool of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai, ChinaSchool of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai, ChinaSchool of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai, ChinaNational Engineering Research Center for Gelatin-based Traditional Chinese Medicine, Dong-E-E-Jiao Co. Ltd., Done-E Country, ChinaNational Engineering Research Center for Gelatin-based Traditional Chinese Medicine, Dong-E-E-Jiao Co. Ltd., Done-E Country, ChinaInstitute of Arthritis Research, Guanghua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, ChinaInstitute of Arthritis Research, Guanghua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, ChinaSchool of Basic Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, ChinaInstitute of Arthritis Research, Guanghua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, ChinaSchool of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai, ChinaEquus asinus L [Equidae; Asini Corii Colla] (donkey-hide gelatin, Ejiao), a well-known traditional Chinese medicine, has been widely used to nourish the blood, especially for women. The aim of this study was to assess the efficacy and safety of Ejiao in blood-deficient patients. A total of 210 participants were recruited and randomly allocated into the placebo control group and Ejiao-treated group (6 g/day). The primary outcomes on the efficacy of Ejiao included traditional Chinese medicine symptom scores, blood indicators, and SF-36. The secondary outcomes were changes in fireness and safety evaluation. Results showed that Ejiao treatment for 8 weeks had significantly improved dizziness symptoms. Among the tested 24 blood biochemical parameters, the hematocrit and red blood cell numbers decreased in the placebo control group, but decreased significantly less in the Ejiao treatment group. The white blood cell and neutrophil counts increased in the Ejiao group but were within the normal range. In addition, the quality of life improved as the scores in SF-36 domains were significantly higher in the Ejiao group. At the same time, there was no significant change in the fire–heat symptoms score or other safety parameters. Considering all these, our study showed that Ejiao has a promising effect in women suffering from blood deficiency without obvious adverse effects.https://www.frontiersin.org/articles/10.3389/fphar.2021.718154/fullasini corii colla (Ejiao)blood deficient symptomsrandomized controlled trialanemiaTCM syndromes
spellingShingle Li Zhang
Li Zhang
Zhongju Xu
Tao Jiang
Jialu Zhang
Pinxian Huang
Jiaqi Tan
Gan Chen
Man Yuan
Zhuo Li
Haibin Liu
Dengfeng Gao
Lianbo Xiao
Hui Feng
Jiatuo Xu
Hongxi Xu
Hongxi Xu
Efficacy and Safety of Ejiao (Asini Corii Colla) in Women With Blood Deficient Symptoms: A Randomized, Double-Blind, and Placebo-Controlled Clinical Trial
Frontiers in Pharmacology
asini corii colla (Ejiao)
blood deficient symptoms
randomized controlled trial
anemia
TCM syndromes
title Efficacy and Safety of Ejiao (Asini Corii Colla) in Women With Blood Deficient Symptoms: A Randomized, Double-Blind, and Placebo-Controlled Clinical Trial
title_full Efficacy and Safety of Ejiao (Asini Corii Colla) in Women With Blood Deficient Symptoms: A Randomized, Double-Blind, and Placebo-Controlled Clinical Trial
title_fullStr Efficacy and Safety of Ejiao (Asini Corii Colla) in Women With Blood Deficient Symptoms: A Randomized, Double-Blind, and Placebo-Controlled Clinical Trial
title_full_unstemmed Efficacy and Safety of Ejiao (Asini Corii Colla) in Women With Blood Deficient Symptoms: A Randomized, Double-Blind, and Placebo-Controlled Clinical Trial
title_short Efficacy and Safety of Ejiao (Asini Corii Colla) in Women With Blood Deficient Symptoms: A Randomized, Double-Blind, and Placebo-Controlled Clinical Trial
title_sort efficacy and safety of ejiao asini corii colla in women with blood deficient symptoms a randomized double blind and placebo controlled clinical trial
topic asini corii colla (Ejiao)
blood deficient symptoms
randomized controlled trial
anemia
TCM syndromes
url https://www.frontiersin.org/articles/10.3389/fphar.2021.718154/full
work_keys_str_mv AT lizhang efficacyandsafetyofejiaoasinicoriicollainwomenwithblooddeficientsymptomsarandomizeddoubleblindandplacebocontrolledclinicaltrial
AT lizhang efficacyandsafetyofejiaoasinicoriicollainwomenwithblooddeficientsymptomsarandomizeddoubleblindandplacebocontrolledclinicaltrial
AT zhongjuxu efficacyandsafetyofejiaoasinicoriicollainwomenwithblooddeficientsymptomsarandomizeddoubleblindandplacebocontrolledclinicaltrial
AT taojiang efficacyandsafetyofejiaoasinicoriicollainwomenwithblooddeficientsymptomsarandomizeddoubleblindandplacebocontrolledclinicaltrial
AT jialuzhang efficacyandsafetyofejiaoasinicoriicollainwomenwithblooddeficientsymptomsarandomizeddoubleblindandplacebocontrolledclinicaltrial
AT pinxianhuang efficacyandsafetyofejiaoasinicoriicollainwomenwithblooddeficientsymptomsarandomizeddoubleblindandplacebocontrolledclinicaltrial
AT jiaqitan efficacyandsafetyofejiaoasinicoriicollainwomenwithblooddeficientsymptomsarandomizeddoubleblindandplacebocontrolledclinicaltrial
AT ganchen efficacyandsafetyofejiaoasinicoriicollainwomenwithblooddeficientsymptomsarandomizeddoubleblindandplacebocontrolledclinicaltrial
AT manyuan efficacyandsafetyofejiaoasinicoriicollainwomenwithblooddeficientsymptomsarandomizeddoubleblindandplacebocontrolledclinicaltrial
AT zhuoli efficacyandsafetyofejiaoasinicoriicollainwomenwithblooddeficientsymptomsarandomizeddoubleblindandplacebocontrolledclinicaltrial
AT haibinliu efficacyandsafetyofejiaoasinicoriicollainwomenwithblooddeficientsymptomsarandomizeddoubleblindandplacebocontrolledclinicaltrial
AT dengfenggao efficacyandsafetyofejiaoasinicoriicollainwomenwithblooddeficientsymptomsarandomizeddoubleblindandplacebocontrolledclinicaltrial
AT lianboxiao efficacyandsafetyofejiaoasinicoriicollainwomenwithblooddeficientsymptomsarandomizeddoubleblindandplacebocontrolledclinicaltrial
AT huifeng efficacyandsafetyofejiaoasinicoriicollainwomenwithblooddeficientsymptomsarandomizeddoubleblindandplacebocontrolledclinicaltrial
AT jiatuoxu efficacyandsafetyofejiaoasinicoriicollainwomenwithblooddeficientsymptomsarandomizeddoubleblindandplacebocontrolledclinicaltrial
AT hongxixu efficacyandsafetyofejiaoasinicoriicollainwomenwithblooddeficientsymptomsarandomizeddoubleblindandplacebocontrolledclinicaltrial
AT hongxixu efficacyandsafetyofejiaoasinicoriicollainwomenwithblooddeficientsymptomsarandomizeddoubleblindandplacebocontrolledclinicaltrial